LINACLOTIDE

LINACLOTIDE was reported 27305 times

LINACLOTIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THERAPEUTIC PRODUCT EFFECT INCREASED 38 0.0326
1 GASTROINTESTINAL MOTILITY DISORDER 173 0.0323
2 FAECES HARD 119 0.0306
3 INFREQUENT BOWEL MOVEMENTS 72 0.0289
4 DYSCHEZIA 71 0.0232
5 BOWEL MOVEMENT IRREGULARITY 177 0.0231
6 ANAL INCONTINENCE 171 0.0190
7 RECTAL TENESMUS 23 0.0185
8 RECTAL PROLAPSE 22 0.0182
9 CERVICAL RADICULOPATHY 13 0.0182
10 GASTROINTESTINAL HYPOMOTILITY 41 0.0182
11 THERAPEUTIC RESPONSE INCREASED 17 0.0181
12 VOLVULUS 39 0.0164
13 ABNORMAL FAECES 121 0.0148
14 GASTROINTESTINAL SOUNDS ABNORMAL 73 0.0147
15 DEFAECATION URGENCY 101 0.0144
16 REBOUND ACID HYPERSECRETION 43 0.0142
17 IMPAIRED GASTRIC EMPTYING 188 0.0138
18 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 14 0.0132
19 GASTRIC DILATATION 22 0.0132
20 OBSTRUCTIVE SLEEP APNOEA SYNDROME 19 0.0130
21 FLATULENCE 721 0.0127
22 THERAPEUTIC PRODUCT EFFECT VARIABLE 49 0.0126
23 DRUG EFFECT VARIABLE 14 0.0124
24 PRODUCT DISPENSING ERROR 266 0.0122
25 NEPHROGENIC ANAEMIA 56 0.0121
26 HYPERPARATHYROIDISM SECONDARY 30 0.0120
27 ABDOMINAL DISTENSION 1188 0.0114
28 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 15 0.0111
29 DRY AGE-RELATED MACULAR DEGENERATION 12 0.0108
30 PHYSICAL PRODUCT LABEL ISSUE 12 0.0101
31 CONSTIPATION 2071 0.0095
32 FUNCTIONAL GASTROINTESTINAL DISORDER 32 0.0092
33 PRODUCT ADMINISTRATION INTERRUPTED 72 0.0092
34 INFUSION SITE HAEMORRHAGE 30 0.0091
35 PRE-EXISTING CONDITION IMPROVED 56 0.0090
36 MEDICAL DEVICE IMPLANTATION 14 0.0089
37 ESSENTIAL HYPERTENSION 16 0.0087
38 FAECALOMA 47 0.0086
39 INFUSION SITE DISCHARGE 15 0.0085
40 CATAPLEXY 12 0.0085
41 PROCTALGIA 52 0.0081
42 PRODUCT PHYSICAL ISSUE 161 0.0080
43 INFUSION SITE PRURITUS 24 0.0076
44 THERAPEUTIC RESPONSE DELAYED 21 0.0075
45 CYSTITIS INTERSTITIAL 12 0.0075
46 DIARRHOEA 4777 0.0074
47 ANORECTAL DISCOMFORT 38 0.0071
48 FAECAL INCONTINENCE 33 0.0069
49 GASTROINTESTINAL PAIN 74 0.0067
50 SINUS OPERATION 16 0.0067
51 WRONG DOSE 16 0.0066
52 THERAPEUTIC PRODUCT EFFECT DELAYED 30 0.0066
53 OESOPHAGEAL SPASM 12 0.0065
54 INFUSION SITE BRUISING 14 0.0065
55 IRRITABLE BOWEL SYNDROME 137 0.0064
56 LARGE INTESTINAL OBSTRUCTION 14 0.0063
57 FREQUENT BOWEL MOVEMENTS 164 0.0061
58 INTENTIONAL PRODUCT MISUSE 525 0.0060
59 MALABSORPTION 31 0.0059
60 STOMA SITE ERYTHEMA 11 0.0059
61 PRODUCT LOT NUMBER ISSUE 13 0.0059
62 STOMA SITE DISCHARGE 16 0.0058
63 FAECES DISCOLOURED 123 0.0057
64 ORAL SURGERY 13 0.0056
65 ENDOMETRIOSIS 26 0.0054
66 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 386 0.0054
67 HAEMORRHOIDS 104 0.0053
68 POOR QUALITY PRODUCT ADMINISTERED 56 0.0053
69 PRODUCT STORAGE ISSUE 20 0.0053
70 SPINAL OPERATION 65 0.0053
71 BRAIN OPERATION 12 0.0053
72 EYE CONTUSION 11 0.0052
73 NECK SURGERY 12 0.0052
74 INTESTINAL OBSTRUCTION 194 0.0051
75 SHOULDER OPERATION 22 0.0051
76 PRODUCT CONTAMINATION PHYSICAL 13 0.0051
77 THERAPEUTIC PRODUCT EFFECT DECREASED 228 0.0051
78 FAECES SOFT 37 0.0051
79 DRUG DISPENSING ERROR 77 0.0050
80 DRUG TITRATION ERROR 13 0.0050
81 EXPIRED PRODUCT ADMINISTERED 167 0.0050
82 ANORECTAL DISORDER 10 0.0050
83 OBSTRUCTION 20 0.0050
84 PRODUCT PACKAGING ISSUE 47 0.0049
85 HAEMORRHOIDAL HAEMORRHAGE 24 0.0049
86 DEVICE INFUSION ISSUE 12 0.0048
87 END STAGE RENAL DISEASE 87 0.0048
88 SNORING 18 0.0048
89 DRUG EFFECT INCREASED 15 0.0047
90 ABDOMINAL PAIN UPPER 969 0.0047
91 PRODUCT STORAGE ERROR 412 0.0047
92 VITAMIN B12 DEFICIENCY 19 0.0047
93 ABDOMINAL PAIN 1089 0.0047
94 REGURGITATION 16 0.0047
95 INSURANCE ISSUE 71 0.0046
96 ILEUS 57 0.0046
97 SLOW SPEECH 11 0.0045
98 THERAPEUTIC RESPONSE DECREASED 273 0.0045
99 INTENTIONAL DOSE OMISSION 128 0.0045
100 CHRONIC KIDNEY DISEASE 340 0.0045
101 SHOULDER ARTHROPLASTY 12 0.0045
102 NECK INJURY 13 0.0044
103 EAR CONGESTION 12 0.0044
104 ABDOMINAL RIGIDITY 12 0.0044
105 PRODUCT LABEL ISSUE 30 0.0044
106 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 787 0.0044
107 MULTIPLE ALLERGIES 34 0.0043
108 VULVOVAGINAL MYCOTIC INFECTION 17 0.0043
109 DIVERTICULITIS 119 0.0043
110 MENOPAUSE 11 0.0043
111 SEASONAL ALLERGY 60 0.0042
112 INCORRECT DRUG ADMINISTRATION RATE 18 0.0042
113 PARANASAL SINUS DISCOMFORT 16 0.0042
114 PRODUCT DISPENSING ISSUE 18 0.0042
115 NONSPECIFIC REACTION 23 0.0042
116 LARGE INTESTINE POLYP 29 0.0042
117 BLOOD CREATININE DECREASED 13 0.0041
118 INABILITY TO AFFORD MEDICATION 41 0.0041
119 INFUSION SITE PAIN 53 0.0041
120 HEREDITARY ANGIOEDEMA 44 0.0041
121 INCORRECT DOSAGE ADMINISTERED 20 0.0041
122 FREEZING PHENOMENON 15 0.0040
123 MUCOUS STOOLS 20 0.0040
124 EYE OPERATION 18 0.0039
125 FEEDING DISORDER 79 0.0039
126 OFF LABEL USE 3406 0.0039
127 SURGERY 227 0.0039
128 KNEE OPERATION 38 0.0039
129 BLADDER DISORDER 37 0.0037
130 BRAIN FOG 58 0.0037
131 MUSCLE STRAIN 32 0.0037
132 HOSPICE CARE 36 0.0036
133 DRUG PRESCRIBING ERROR 70 0.0036
134 CYSTIC FIBROSIS 20 0.0036
135 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 198 0.0036
136 LYME DISEASE 12 0.0036
137 VITAMIN D DEFICIENCY 35 0.0036
138 EPIGASTRIC DISCOMFORT 14 0.0036
139 ORAL INFECTION 14 0.0036
140 INFUSION SITE ERYTHEMA 30 0.0036
141 COLITIS ISCHAEMIC 24 0.0036
142 BLOOD POTASSIUM DECREASED 106 0.0035
143 SLEEP APNOEA SYNDROME 67 0.0035
144 ABDOMINAL HERNIA 16 0.0035
145 INCONTINENCE 37 0.0035
146 INFUSION SITE SWELLING 22 0.0035
147 INTRACRANIAL ANEURYSM 14 0.0035
148 DRUG INEFFECTIVE 4586 0.0035
149 HIATUS HERNIA 45 0.0035
150 CHRONIC SINUSITIS 13 0.0035
151 FOOT OPERATION 17 0.0034
152 UNEVALUABLE EVENT 259 0.0034
153 PARANASAL SINUS HYPERSECRETION 13 0.0034
154 VITAMIN D DECREASED 29 0.0034
155 SPINAL STENOSIS 14 0.0034
156 INFUSION SITE EXTRAVASATION 21 0.0034
157 ILLNESS 347 0.0034
158 DELUSION 52 0.0033
159 PRODUCT RESIDUE PRESENT 18 0.0033
160 IRON DEFICIENCY 15 0.0033
161 LYMPHOEDEMA 23 0.0033
162 DRUG EFFECT DELAYED 15 0.0033
163 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
164 DISABILITY 65 0.0033
165 POST-TRAUMATIC STRESS DISORDER 22 0.0033
166 GASTROOESOPHAGEAL REFLUX DISEASE 264 0.0033
167 PRODUCT PRESCRIBING ERROR 78 0.0033
168 GASTROINTESTINAL DISORDER 291 0.0032
169 MICTURITION URGENCY 37 0.0032
170 FOOD ALLERGY 25 0.0032
171 CONCUSSION 25 0.0032
172 GALLBLADDER OPERATION 13 0.0032
173 HERNIA 62 0.0032
174 BACK DISORDER 52 0.0032
175 COLECTOMY 18 0.0032
176 SINUS DISORDER 63 0.0032
177 SKIN ABRASION 15 0.0032
178 HYPOPNOEA 11 0.0032
179 ABDOMINAL ADHESIONS 10 0.0032
180 CHOLECYSTECTOMY 36 0.0031
181 IRON DEFICIENCY ANAEMIA 29 0.0031
182 MALNUTRITION 35 0.0031
183 THYROID MASS 12 0.0031
184 DEHYDRATION 415 0.0031
185 MACULOPATHY 11 0.0031
186 REHABILITATION THERAPY 12 0.0031
187 DIVERTICULUM 22 0.0031
188 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 19 0.0031
189 POST PROCEDURAL INFECTION 25 0.0031
190 FOOT FRACTURE 58 0.0031
191 ERUCTATION 59 0.0030
192 HEART RATE ABNORMAL 17 0.0030
193 INTERVERTEBRAL DISC DEGENERATION 28 0.0030
194 WOUND HAEMORRHAGE 11 0.0030
195 HIP SURGERY 16 0.0030
196 RECTAL HAEMORRHAGE 126 0.0029
197 ELECTROLYTE IMBALANCE 34 0.0029
198 NEURALGIA 71 0.0029
199 LIMB OPERATION 14 0.0029
200 ILEUS PARALYTIC 13 0.0029
201 PRODUCT DISTRIBUTION ISSUE 27 0.0029
202 FEELING OF BODY TEMPERATURE CHANGE 17 0.0029
203 HYSTERECTOMY 25 0.0029
204 DECREASED INTEREST 17 0.0029
205 SENSITIVE SKIN 21 0.0028
206 HALLUCINATION 214 0.0028
207 ABDOMINAL DISCOMFORT 476 0.0028
208 TONGUE DISCOMFORT 12 0.0028
209 PRODUCT ADMINISTRATION ERROR 57 0.0028
210 ROTATOR CUFF SYNDROME 36 0.0028
211 ANAL FISSURE 15 0.0028
212 SKIN ODOUR ABNORMAL 11 0.0028
213 SUSPECTED SUICIDE 13 0.0028
214 MIGRAINE 263 0.0028
215 DYSPEPSIA 271 0.0028
216 GAIT INABILITY 92 0.0028
217 KIDNEY INFECTION 54 0.0027
218 INTERVERTEBRAL DISC PROTRUSION 60 0.0027
219 SOMNAMBULISM 18 0.0027
220 INTENTIONAL UNDERDOSE 20 0.0027
221 WALKING AID USER 18 0.0027
222 PRODUCT USE COMPLAINT 43 0.0027
223 APPETITE DISORDER 18 0.0027
224 SPINAL FUSION SURGERY 11 0.0027
225 GLUCOSE TOLERANCE IMPAIRED 16 0.0027
226 ON AND OFF PHENOMENON 15 0.0027
227 PERIPHERAL VENOUS DISEASE 11 0.0027
228 HEAD INJURY 85 0.0027
229 CARDIAC PACEMAKER INSERTION 16 0.0027
230 FIBROMYALGIA 65 0.0027
231 BLOOD MAGNESIUM DECREASED 23 0.0027
232 RESTLESS LEGS SYNDROME 48 0.0026
233 PANCREATIC DISORDER 13 0.0026
234 EATING DISORDER 56 0.0026
235 BLOOD PRESSURE DIASTOLIC INCREASED 12 0.0026
236 POLYP 17 0.0026
237 PHARYNGITIS STREPTOCOCCAL 28 0.0026
238 SCOLIOSIS 16 0.0026
239 DIZZINESS POSTURAL 25 0.0026
240 INTERVERTEBRAL DISC DISORDER 11 0.0026
241 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 123 0.0026
242 TIBIA FRACTURE 12 0.0026
243 HORDEOLUM 11 0.0025
244 BRADYKINESIA 15 0.0025
245 COVID-19 PNEUMONIA 30 0.0025
246 HAND FRACTURE 18 0.0025
247 ABDOMINAL PAIN LOWER 64 0.0025
248 THYROID DISORDER 39 0.0025
249 LIGAMENT SPRAIN 25 0.0025
250 SMALL INTESTINAL OBSTRUCTION 31 0.0025
251 NERVE INJURY 28 0.0025
252 URINE OUTPUT DECREASED 22 0.0025
253 DYSPHEMIA 11 0.0025
254 BLOOD SODIUM DECREASED 47 0.0025
255 VULVOVAGINAL PAIN 12 0.0025
256 SINUSITIS 255 0.0025
257 MUSCLE SPASMS 453 0.0025
258 THERAPY INTERRUPTED 176 0.0025
259 DRY THROAT 25 0.0025
260 DISCOMFORT 150 0.0025
261 GASTROINTESTINAL INFECTION 22 0.0025
262 HAEMATOCHEZIA 135 0.0024
263 BLOOD IRON DECREASED 29 0.0024
264 PRODUCT DOSE OMISSION 159 0.0024
265 MACULAR DEGENERATION 29 0.0024
266 KNEE ARTHROPLASTY 51 0.0024
267 WRIST FRACTURE 29 0.0024
268 INTESTINAL RESECTION 13 0.0024
269 BIPOLAR DISORDER 26 0.0024
270 SKIN LACERATION 26 0.0024
271 ANKLE FRACTURE 37 0.0024
272 DYSKINESIA 97 0.0024
273 PRODUCT SOLUBILITY ABNORMAL 12 0.0024
274 DERMATITIS CONTACT 27 0.0024
275 IMPAIRED QUALITY OF LIFE 34 0.0024
276 URINARY TRACT INFECTION 403 0.0024
277 CARPAL TUNNEL SYNDROME 33 0.0024
278 COELIAC DISEASE 23 0.0023
279 GASTROENTERITIS VIRAL 42 0.0023
280 OROPHARYNGEAL DISCOMFORT 21 0.0023
281 BENIGN PROSTATIC HYPERPLASIA 12 0.0023
282 RESPIRATION ABNORMAL 16 0.0023
283 ORAL DISORDER 17 0.0023
284 UPPER-AIRWAY COUGH SYNDROME 19 0.0023
285 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 164 0.0023
286 LARGE INTESTINE PERFORATION 16 0.0023
287 HYPERSOMNIA 66 0.0023
288 CEREBRAL DISORDER 17 0.0023
289 GASTROINTESTINAL INFLAMMATION 18 0.0023
290 WEIGHT FLUCTUATION 24 0.0023
291 PERONEAL NERVE PALSY 13 0.0023
292 GASTRITIS 60 0.0023
293 GROIN PAIN 20 0.0023
294 MENISCUS INJURY 14 0.0023
295 BLOOD PRESSURE ABNORMAL 45 0.0023
296 EAR PAIN 44 0.0023
297 FLUID RETENTION 115 0.0023
298 HORMONE LEVEL ABNORMAL 11 0.0023
299 EYE PAIN 127 0.0022
300 FLANK PAIN 21 0.0022
301 FALL 743 0.0022
302 ORAL DISCOMFORT 31 0.0022
303 CYSTITIS 71 0.0022
304 TEMPERATURE INTOLERANCE 23 0.0022
305 DYSURIA 82 0.0022
306 OCULAR DISCOMFORT 25 0.0022
307 DYSSTASIA 65 0.0022
308 POSTOPERATIVE WOUND INFECTION 15 0.0022
309 HIP ARTHROPLASTY 34 0.0022
310 URINE ODOUR ABNORMAL 13 0.0022
311 ANEURYSM 11 0.0022
312 DYSPHAGIA 209 0.0022
313 FLUID INTAKE REDUCED 11 0.0022
314 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 445 0.0022
315 MIDDLE INSOMNIA 41 0.0022
316 SYMPTOM RECURRENCE 13 0.0022
317 THERAPEUTIC RESPONSE UNEXPECTED 97 0.0022
318 NEPHROLITHIASIS 99 0.0022
319 PRODUCT COMMUNICATION ISSUE 19 0.0022
320 INITIAL INSOMNIA 22 0.0021
321 BLOOD ALBUMIN DECREASED 17 0.0021
322 POST PROCEDURAL COMPLICATION 41 0.0021
323 TOOTH INFECTION 28 0.0021
324 PERIORBITAL SWELLING 12 0.0021
325 BACK INJURY 23 0.0021
326 OSTEOPENIA 32 0.0021
327 BALANCE DISORDER 182 0.0021
328 OVARIAN CYST 21 0.0021
329 UPPER RESPIRATORY TRACT INFECTION 97 0.0021
330 MUSCLE TIGHTNESS 34 0.0021
331 PRODUCT DOSE OMISSION IN ERROR 59 0.0021
332 LOWER LIMB FRACTURE 40 0.0021
333 TUBULOINTERSTITIAL NEPHRITIS 39 0.0021
334 PYELONEPHRITIS 18 0.0021
335 RESPIRATORY TRACT CONGESTION 33 0.0021
336 OSTEOARTHRITIS 88 0.0021
337 THIRST 37 0.0021
338 FUNGAL INFECTION 69 0.0021
339 ORTHOSTATIC HYPOTENSION 36 0.0021
340 POLLAKIURIA 86 0.0021
341 LIMB INJURY 56 0.0021
342 COMPRESSION FRACTURE 11 0.0021
343 HIP FRACTURE 66 0.0021
344 ORAL CANDIDIASIS 27 0.0020
345 SPINAL OSTEOARTHRITIS 18 0.0020
346 EAR DISCOMFORT 21 0.0020
347 GASTRIC DISORDER 70 0.0020
348 GINGIVITIS 11 0.0020
349 HALLUCINATION, VISUAL 43 0.0020
350 HEAD DISCOMFORT 36 0.0020
351 ENERGY INCREASED 12 0.0020
352 DIARRHOEA HAEMORRHAGIC 19 0.0020
353 POOR VENOUS ACCESS 21 0.0020
354 ABDOMINAL TENDERNESS 10 0.0020
355 CANDIDA INFECTION 34 0.0020
356 PRODUCT DOSE OMISSION ISSUE 592 0.0020
357 COLON CANCER 30 0.0020
358 INCORRECT DOSE ADMINISTERED 459 0.0020
359 DRY MOUTH 163 0.0020
360 INCOHERENT 13 0.0020
361 PERIPHERAL SWELLING 309 0.0020
362 PRESCRIBED UNDERDOSE 40 0.0020
363 NECK PAIN 112 0.0020
364 BRONCHITIS 148 0.0020
365 NERVOUSNESS 104 0.0020
366 RHINITIS 16 0.0020
367 DRUG DOSE OMISSION 328 0.0020
368 CARDIAC OPERATION 17 0.0020
369 EXOSTOSIS 18 0.0020
370 WEIGHT INCREASED 441 0.0020
371 CARDIAC FAILURE ACUTE 13 0.0019
372 CHROMATURIA 44 0.0019
373 RIB FRACTURE 40 0.0019
374 SCIATICA 31 0.0019
375 LOCALISED INFECTION 47 0.0019
376 PHARYNGEAL SWELLING 19 0.0019
377 HUNGER 27 0.0019
378 RENAL TUBULAR NECROSIS 19 0.0019
379 URINARY INCONTINENCE 57 0.0019
380 WEIGHT DECREASED 537 0.0019
381 NAUSEA 1522 0.0019
382 OSTEOPOROSIS 79 0.0019
383 RENAL INJURY 57 0.0019
384 DEVICE OCCLUSION 27 0.0019
385 SWELLING OF EYELID 12 0.0019
386 PROCEDURAL PAIN 53 0.0019
387 UPPER LIMB FRACTURE 38 0.0019
388 DECREASED APPETITE 442 0.0019
389 SPUTUM DISCOLOURED 18 0.0019
390 NOCTURIA 23 0.0019
391 THERAPEUTIC RESPONSE CHANGED 12 0.0019
392 MUSCULOSKELETAL DISORDER 36 0.0019
393 RENAL CYST 15 0.0019
394 URINARY RETENTION 63 0.0019
395 FEELING DRUNK 14 0.0019
396 FOREIGN BODY SENSATION IN EYES 12 0.0019
397 BACK PAIN 436 0.0019
398 RETCHING 40 0.0019
399 NASAL CONGESTION 110 0.0019
400 SCAR 32 0.0019
401 POOR QUALITY SLEEP 40 0.0019
402 CARDIAC FLUTTER 12 0.0019
403 SLEEP DISORDER 131 0.0019
404 MEMORY IMPAIRMENT 254 0.0018
405 NERVE COMPRESSION 17 0.0018
406 RESPIRATORY SYNCYTIAL VIRUS INFECTION 16 0.0018
407 SECRETION DISCHARGE 23 0.0018
408 THERAPY CESSATION 94 0.0018
409 ORAL PAIN 41 0.0018
410 DRY EYE 91 0.0018
411 DYSGRAPHIA 12 0.0018
412 PULMONARY MASS 27 0.0018
413 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
414 PANIC ATTACK 66 0.0018
415 PHOTOPHOBIA 34 0.0018
416 PELVIC FRACTURE 14 0.0018
417 JOINT DISLOCATION 19 0.0018
418 FACIAL PAIN 16 0.0018
419 BLOOD URINE PRESENT 34 0.0018
420 BLOOD PRESSURE DECREASED 119 0.0018
421 FEELING ABNORMAL 429 0.0018
422 AFFECTIVE DISORDER 14 0.0018
423 LIMB DISCOMFORT 55 0.0018
424 DEPRESSION 404 0.0018
425 OROPHARYNGEAL PAIN 164 0.0018
426 DRUG EFFECT DECREASED 95 0.0018
427 DIZZINESS 879 0.0018
428 DECREASED ACTIVITY 19 0.0018
429 HYPOPHOSPHATAEMIA 13 0.0018
430 INTENTIONAL PRODUCT USE ISSUE 154 0.0018
431 HYPERLIPIDAEMIA 21 0.0018
432 NASAL DRYNESS 11 0.0018
433 DRUG EFFECT LESS THAN EXPECTED 26 0.0018
434 BEDRIDDEN 23 0.0017
435 ASTHENIA 656 0.0017
436 PALPITATIONS 204 0.0017
437 THROAT IRRITATION 78 0.0017
438 ANXIETY 494 0.0017
439 CONTUSION 167 0.0017
440 BLOOD GLUCOSE FLUCTUATION 19 0.0017
441 MYASTHENIA GRAVIS 14 0.0017
442 FRUSTRATION TOLERANCE DECREASED 14 0.0017
443 TREMOR 287 0.0017
444 THERAPY CHANGE 17 0.0017
445 EAR INFECTION 46 0.0017
446 DYSPHONIA 101 0.0017
447 MULTIPLE SCLEROSIS 82 0.0017
448 NAIL DISORDER 15 0.0017
449 SEIZURE 198 0.0017
450 TOOTHACHE 31 0.0017
451 HEADACHE 1073 0.0017
452 COVID-19 300 0.0017
453 PAIN IN JAW 48 0.0017
454 RENAL FAILURE 223 0.0017
455 FEELING JITTERY 32 0.0017
456 CHOLECYSTITIS 20 0.0017
457 ANHEDONIA 44 0.0017
458 SOMNOLENCE 337 0.0017
459 THINKING ABNORMAL 31 0.0017
460 HYPOTHYROIDISM 53 0.0017
461 TONGUE DISORDER 12 0.0017
462 ELECTROCARDIOGRAM ABNORMAL 13 0.0017
463 COGNITIVE DISORDER 77 0.0016
464 MULTIPLE SCLEROSIS RELAPSE 113 0.0016
465 WOUND INFECTION 18 0.0016
466 CHEST PAIN 304 0.0016
467 PNEUMONIA ASPIRATION 41 0.0016
468 GAIT DISTURBANCE 314 0.0016
469 BREAST MASS 11 0.0016
470 EYE DISCHARGE 17 0.0016
471 PRODUCTIVE COUGH 78 0.0016
472 PRODUCT CONTAINER ISSUE 14 0.0016
473 TOOTH FRACTURE 18 0.0016
474 BRONCHIECTASIS 11 0.0016
475 TENDERNESS 17 0.0016
476 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 85 0.0016
477 TASTE DISORDER 33 0.0016
478 BLOOD PRESSURE FLUCTUATION 39 0.0016
479 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
480 ARTHROPOD BITE 12 0.0016
481 INSOMNIA 431 0.0016
482 GOUT 29 0.0016
483 ABNORMAL LOSS OF WEIGHT 11 0.0016
484 PAIN 991 0.0016
485 RESPIRATORY TRACT INFECTION 42 0.0016
486 BLOOD PRESSURE INCREASED 246 0.0016
487 BACTERIAL INFECTION 30 0.0016
488 PRODUCT PRESCRIBING ISSUE 35 0.0016
489 APPENDICITIS 15 0.0016
490 SKIN INFECTION 18 0.0016
491 INTESTINAL PERFORATION 18 0.0016
492 ONYCHOCLASIS 11 0.0016
493 EYE IRRITATION 92 0.0016
494 BREAST PAIN 17 0.0016
495 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 27 0.0016
496 COMPLICATION ASSOCIATED WITH DEVICE 23 0.0016
497 COLITIS 60 0.0016
498 MALAISE 693 0.0016
499 GASTRIC ULCER 30 0.0016
500 VERTIGO 96 0.0016
501 SPINAL COMPRESSION FRACTURE 13 0.0016
502 TOOTH ABSCESS 16 0.0016
503 TRANSIENT ISCHAEMIC ATTACK 53 0.0016
504 GALLBLADDER DISORDER 28 0.0016
505 ACUTE KIDNEY INJURY 240 0.0016
506 THERAPEUTIC RESPONSE SHORTENED 52 0.0016
507 MOUTH ULCERATION 33 0.0016
508 MENTAL DISORDER 68 0.0016
509 SEROTONIN SYNDROME 30 0.0016
510 FATIGUE 1213 0.0016
511 LYMPHADENOPATHY 55 0.0016
512 PRODUCT TASTE ABNORMAL 21 0.0015
513 SPINAL FRACTURE 31 0.0015
514 HEART RATE INCREASED 153 0.0015
515 DENTAL CARIES 17 0.0015
516 VIRAL INFECTION 51 0.0015
517 MOBILITY DECREASED 110 0.0015
518 TOOTH EXTRACTION 19 0.0015
519 PARAESTHESIA ORAL 22 0.0015
520 ASTHMA 172 0.0015
521 ABNORMAL DREAMS 42 0.0015
522 THROAT TIGHTNESS 41 0.0015
523 MUSCULAR WEAKNESS 172 0.0015
524 LETHARGY 87 0.0015
525 MUSCULOSKELETAL DISCOMFORT 26 0.0015
526 FEELING COLD 42 0.0015
527 SPEECH DISORDER 79 0.0015
528 GINGIVAL PAIN 12 0.0015
529 ACCIDENT 18 0.0015
530 MAJOR DEPRESSION 11 0.0015
531 RENAL DISORDER 70 0.0015
532 HYPERHIDROSIS 193 0.0015
533 SKIN SWELLING 13 0.0015
534 OBSESSIVE-COMPULSIVE DISORDER 12 0.0015
535 SKIN HAEMORRHAGE 22 0.0015
536 PRESYNCOPE 36 0.0015
537 SPINAL DISORDER 14 0.0015
538 BLOOD POTASSIUM INCREASED 24 0.0015
539 NEUROPATHY PERIPHERAL 140 0.0015
540 LYMPHOCYTE COUNT DECREASED 26 0.0015
541 GENERAL SYMPTOM 11 0.0015
542 MUSCLE SPASTICITY 18 0.0015
543 HYPOACUSIS 63 0.0015
544 HICCUPS 12 0.0015
545 INFLUENZA 163 0.0015
546 HEART RATE IRREGULAR 33 0.0015
547 TINNITUS 67 0.0015
548 NODULE 19 0.0015
549 DEAFNESS 38 0.0015
550 HYPOKALAEMIA 67 0.0015
551 EYE SWELLING 54 0.0015
552 ULCER 23 0.0014
553 FOOT DEFORMITY 16 0.0014
554 TOOTH DISORDER 32 0.0014
555 ARTHRITIS 113 0.0014
556 PRURITUS GENERALISED 31 0.0014
557 BACTERAEMIA 17 0.0014
558 PRODUCT USE ISSUE 269 0.0014
559 LIP DRY 13 0.0014
560 HYPOAESTHESIA 214 0.0014
561 VOMITING 668 0.0014
562 MUSCLE ATROPHY 18 0.0014
563 EYE INFECTION 16 0.0014
564 RENAL PAIN 15 0.0014
565 BRAIN NEOPLASM 13 0.0014
566 INCREASED TENDENCY TO BRUISE 13 0.0014
567 FACIAL PARALYSIS 12 0.0014
568 DYSPNOEA EXERTIONAL 53 0.0014
569 FEELING HOT 86 0.0014
570 HEART RATE DECREASED 49 0.0014
571 PRESCRIBED OVERDOSE 27 0.0014
572 PHOTOSENSITIVITY REACTION 23 0.0014
573 NEPHROPATHY 13 0.0014
574 HERPES ZOSTER 80 0.0014
575 ACUTE HEPATIC FAILURE 19 0.0014
576 PAIN IN EXTREMITY 409 0.0014
577 FURUNCLE 11 0.0014
578 BONE PAIN 81 0.0014
579 LOSS OF CONSCIOUSNESS 177 0.0014
580 CONFUSIONAL STATE 223 0.0014
581 CHOLELITHIASIS 45 0.0014
582 RESPIRATORY DISORDER 41 0.0014
583 HYPOPHAGIA 35 0.0014
584 ANKYLOSING SPONDYLITIS 18 0.0014
585 NIGHT SWEATS 44 0.0014
586 PRODUCT USE IN UNAPPROVED INDICATION 338 0.0014
587 EYE INFLAMMATION 13 0.0014
588 MUSCLE DISORDER 11 0.0014
589 BLOOD TEST ABNORMAL 19 0.0014
590 DECUBITUS ULCER 11 0.0013
591 EYE HAEMORRHAGE 18 0.0013
592 QUALITY OF LIFE DECREASED 18 0.0013
593 FULL BLOOD COUNT DECREASED 27 0.0013
594 ROAD TRAFFIC ACCIDENT 56 0.0013
595 HAIR DISORDER 11 0.0013
596 PARANOIA 23 0.0013
597 HEPATIC CIRRHOSIS 25 0.0013
598 THYROID CANCER 16 0.0013
599 SYNCOPE 133 0.0013
600 BURNING SENSATION 93 0.0013
601 LIP SWELLING 44 0.0013
602 IMPAIRED DRIVING ABILITY 15 0.0013
603 GINGIVAL BLEEDING 18 0.0013
604 MELAENA 29 0.0013
605 SWELLING 123 0.0013
606 JOINT INJURY 28 0.0013
607 BODY HEIGHT DECREASED 14 0.0013
608 HYPOKINESIA 19 0.0013
609 COLD SWEAT 23 0.0013
610 BLOOD THYROID STIMULATING HORMONE INCREASED 12 0.0013
611 VISION BLURRED 179 0.0013
612 STAPHYLOCOCCAL INFECTION 43 0.0013
613 UROSEPSIS 12 0.0013
614 BRAIN INJURY 13 0.0013
615 TENDON RUPTURE 16 0.0013
616 INCORRECT PRODUCT STORAGE 17 0.0013
617 FEMUR FRACTURE 40 0.0013
618 OEDEMA 70 0.0013
619 APHONIA 18 0.0013
620 HOT FLUSH 97 0.0013
621 ORAL HERPES 25 0.0013
622 ADVERSE DRUG REACTION 115 0.0013
623 SPINAL PAIN 15 0.0013
624 CHEST DISCOMFORT 131 0.0013
625 SKIN FISSURES 25 0.0013
626 INFLAMMATION 66 0.0013
627 MULTIPLE FRACTURES 21 0.0013
628 PSYCHOLOGICAL TRAUMA 11 0.0013
629 EPISTAXIS 95 0.0013
630 PRURITUS 486 0.0013
631 FEAR 34 0.0013
632 ATAXIA 15 0.0013
633 HYPOAESTHESIA ORAL 19 0.0013
634 MUSCLE TWITCHING 29 0.0013
635 PARALYSIS 18 0.0013
636 BLOOD CALCIUM INCREASED 11 0.0013
637 SWOLLEN TONGUE 39 0.0012
638 SNEEZING 28 0.0012
639 GLAUCOMA 24 0.0012
640 AMNESIA 81 0.0012
641 INFECTION 180 0.0012
642 HOSPITALISATION 191 0.0012
643 CATARACT 74 0.0012
644 NIGHTMARE 43 0.0012
645 DYSPNOEA 702 0.0012
646 MENTAL IMPAIRMENT 30 0.0012
647 MITRAL VALVE INCOMPETENCE 14 0.0012
648 PNEUMONIA 400 0.0012
649 HEPATIC STEATOSIS 23 0.0012
650 HYPERTENSION 261 0.0012
651 BLOOD PRESSURE SYSTOLIC INCREASED 24 0.0012
652 DEPRESSED MOOD 65 0.0012
653 BLOOD GLUCOSE DECREASED 59 0.0012
654 TENDONITIS 19 0.0012
655 INTERNAL HAEMORRHAGE 14 0.0012
656 APHASIA 37 0.0012
657 GLOMERULAR FILTRATION RATE DECREASED 15 0.0012
658 EYE PRURITUS 41 0.0012
659 MASS 17 0.0012
660 COMPLETED SUICIDE 101 0.0012
661 CHILLS 142 0.0012
662 VISUAL IMPAIRMENT 150 0.0012
663 INCREASED APPETITE 23 0.0012
664 ALOPECIA 236 0.0012
665 CONDITION AGGRAVATED 365 0.0012
666 SALIVARY HYPERSECRETION 12 0.0012
667 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
668 EXPOSURE VIA SKIN CONTACT 31 0.0012
669 DIPLOPIA 31 0.0012
670 PULMONARY THROMBOSIS 13 0.0012
671 CELLULITIS 60 0.0012
672 ARTHRALGIA 495 0.0012
673 RED BLOOD CELL COUNT DECREASED 34 0.0012
674 CONTRAINDICATED PRODUCT ADMINISTERED 36 0.0012
675 ECONOMIC PROBLEM 18 0.0012
676 SINUS CONGESTION 16 0.0012
677 OCULAR HYPERAEMIA 56 0.0012
678 BLINDNESS 48 0.0012
679 SLUGGISHNESS 12 0.0012
680 MUSCULOSKELETAL STIFFNESS 103 0.0012
681 BLISTER 66 0.0012
682 SWELLING FACE 76 0.0012
683 RASH PRURITIC 63 0.0012
684 BLOOD CALCIUM DECREASED 13 0.0012
685 VENTRICULAR EXTRASYSTOLES 12 0.0012
686 SYSTEMIC LUPUS ERYTHEMATOSUS 41 0.0012
687 STOMATITIS 70 0.0012
688 NEOPLASM MALIGNANT 77 0.0012
689 ANGINA PECTORIS 33 0.0012
690 COUGH 322 0.0011
691 RHINORRHOEA 74 0.0011
692 JOINT STIFFNESS 30 0.0011
693 RASH 497 0.0011
694 OXYGEN SATURATION DECREASED 64 0.0011
695 IMMUNE SYSTEM DISORDER 15 0.0011
696 PSORIATIC ARTHROPATHY 46 0.0011
697 SKIN DISCOLOURATION 52 0.0011
698 CHOKING 22 0.0011
699 EYE DISORDER 37 0.0011
700 HAIR COLOUR CHANGES 14 0.0011
701 TREATMENT FAILURE 93 0.0011
702 LUNG DISORDER 55 0.0011
703 SENSORY DISTURBANCE 18 0.0011
704 TOXIC EPIDERMAL NECROLYSIS 17 0.0011
705 VITREOUS FLOATERS 11 0.0011
706 NASOPHARYNGITIS 206 0.0011
707 PRODUCT QUALITY ISSUE 151 0.0011
708 ADVERSE EVENT 102 0.0011
709 UVEITIS 15 0.0011
710 HYPERTHYROIDISM 16 0.0011
711 PRODUCT COMPLAINT 28 0.0011
712 DYSGEUSIA 82 0.0011
713 CARDIAC DISORDER 103 0.0011
714 CLOSTRIDIUM DIFFICILE INFECTION 24 0.0011
715 ASPIRATION 12 0.0011
716 MYALGIA 186 0.0011
717 SEPSIS 122 0.0011
718 SKIN LESION 30 0.0011
719 LACRIMATION INCREASED 33 0.0011
720 MYOCLONUS 13 0.0011
721 MUSCLE RIGIDITY 13 0.0011
722 SKIN ULCER 28 0.0011
723 HYPERSENSITIVITY 201 0.0011
724 MENTAL STATUS CHANGES 30 0.0011
725 HYPERTENSIVE CRISIS 12 0.0011
726 DISTURBANCE IN ATTENTION 58 0.0011
727 PARAESTHESIA 169 0.0011
728 PNEUMOTHORAX 17 0.0011
729 CARDIAC ARREST 88 0.0011
730 IRRITABILITY 64 0.0011
731 WHEEZING 63 0.0011
732 EXTRA DOSE ADMINISTERED 43 0.0011
733 PANCREATITIS 56 0.0011
734 MOVEMENT DISORDER 34 0.0011
735 RASH MACULAR 37 0.0011
736 SCAB 12 0.0011
737 URTICARIA 176 0.0010
738 ATRIAL FIBRILLATION 102 0.0010
739 THERAPY NON-RESPONDER 47 0.0010
740 JOINT RANGE OF MOTION DECREASED 14 0.0010
741 AGEUSIA 26 0.0010
742 PHARYNGEAL OEDEMA 16 0.0010
743 DEVICE RELATED INFECTION 16 0.0010
744 IMPAIRED HEALING 34 0.0010
745 DISORIENTATION 41 0.0010
746 MUSCULOSKELETAL CHEST PAIN 16 0.0010
747 HEPATIC ENZYME INCREASED 70 0.0010
748 SUICIDAL IDEATION 94 0.0010
749 RASH PAPULAR 23 0.0010
750 HYPOXIA 36 0.0010
751 JOINT SWELLING 123 0.0010
752 INCORRECT PRODUCT ADMINISTRATION DURATION 22 0.0010
753 PRODUCT AVAILABILITY ISSUE 23 0.0010
754 DYSARTHRIA 38 0.0010
755 OESOPHAGITIS 11 0.0010
756 CEREBRAL HAEMORRHAGE 36 0.0010
757 OBESITY 16 0.0010
758 DEMENTIA 28 0.0010
759 INFLUENZA LIKE ILLNESS 82 0.0010
760 DRUG INTOLERANCE 96 0.0010
761 NERVOUS SYSTEM DISORDER 31 0.0010
762 OEDEMA PERIPHERAL 121 0.0010
763 HYPOTENSION 199 0.0010
764 BLOOD CHOLESTEROL INCREASED 46 0.0010
765 DIALYSIS 14 0.0010
766 INJECTION SITE URTICARIA 24 0.0010
767 ANAPHYLACTIC REACTION 54 0.0010
768 ENCEPHALOPATHY 24 0.0010
769 SKIN CANCER 21 0.0010
770 MUSCULOSKELETAL PAIN 51 0.0010
771 GENERALISED OEDEMA 12 0.0010
772 HAEMATOMA 25 0.0010
773 RENAL IMPAIRMENT 81 0.0010
774 APATHY 14 0.0010
775 HAEMATOCRIT DECREASED 19 0.0010
776 GASTRIC HAEMORRHAGE 11 0.0010
777 LIVER DISORDER 42 0.0009
778 PERIPHERAL COLDNESS 13 0.0009
779 RASH ERYTHEMATOUS 45 0.0009
780 MOOD SWINGS 30 0.0009
781 AGITATION 69 0.0009
782 GLOSSODYNIA 21 0.0009
783 HEPATIC FUNCTION ABNORMAL 35 0.0009
784 DRUG EFFECT INCOMPLETE 34 0.0009
785 CARDIAC FAILURE CONGESTIVE 75 0.0009
786 HAEMOPTYSIS 26 0.0009
787 BODY TEMPERATURE INCREASED 19 0.0009
788 DERMATITIS ATOPIC 49 0.0009
789 DELIRIUM 32 0.0009
790 DEVICE ISSUE 82 0.0009
791 CRYING 33 0.0009
792 HAIR TEXTURE ABNORMAL 12 0.0009
793 BLOOD UREA INCREASED 15 0.0009
794 TREATMENT NONCOMPLIANCE 49 0.0009
795 FLUSHING 91 0.0009
796 DRUG INTERACTION 142 0.0009
797 WOUND 25 0.0009
798 CARDIOMEGALY 11 0.0009
799 HYPONATRAEMIA 50 0.0009
800 PHARYNGITIS 11 0.0009
801 CYST 11 0.0009
802 ACUTE RESPIRATORY FAILURE 17 0.0009
803 HALLUCINATION, AUDITORY 14 0.0009
804 BONE DISORDER 16 0.0009
805 CORONARY ARTERY OCCLUSION 12 0.0009
806 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
807 IMMUNODEFICIENCY 13 0.0009
808 PERICARDIAL EFFUSION 20 0.0009
809 DERMATITIS 18 0.0009
810 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 29 0.0009
811 BLOOD COUNT ABNORMAL 13 0.0009
812 DEVICE DISLOCATION 37 0.0009
813 RESTLESSNESS 31 0.0008
814 GENERALISED TONIC-CLONIC SEIZURE 14 0.0008
815 ARTHROPATHY 47 0.0008
816 MOOD ALTERED 23 0.0008
817 HAEMOGLOBIN DECREASED 86 0.0008
818 BASAL CELL CARCINOMA 13 0.0008
819 ABNORMAL BEHAVIOUR 33 0.0008
820 DRY SKIN 111 0.0008
821 UNDERDOSE 60 0.0008
822 WHITE BLOOD CELL COUNT DECREASED 89 0.0008
823 CEREBROVASCULAR ACCIDENT 138 0.0008
824 UNRESPONSIVE TO STIMULI 21 0.0008
825 PSYCHOTIC DISORDER 24 0.0008
826 PULMONARY OEDEMA 36 0.0008
827 SEDATION 21 0.0008
828 DIABETES MELLITUS 61 0.0008
829 INFUSION RELATED REACTION 53 0.0008
830 THROMBOSIS 64 0.0008
831 IMPAIRED WORK ABILITY 17 0.0008
832 SKIN EXFOLIATION 67 0.0008
833 FRACTURE 15 0.0008
834 ALTERED STATE OF CONSCIOUSNESS 17 0.0008
835 ECZEMA 41 0.0008
836 ANAEMIA 149 0.0008
837 BLOOD CREATININE INCREASED 51 0.0008
838 SKIN DISORDER 26 0.0008
839 ERYTHEMA 159 0.0008
840 TYPE 2 DIABETES MELLITUS 26 0.0008
841 PELVIC PAIN 14 0.0008
842 SUBDURAL HAEMATOMA 11 0.0008
843 PYREXIA 265 0.0008
844 GASTROINTESTINAL HAEMORRHAGE 64 0.0008
845 ALANINE AMINOTRANSFERASE INCREASED 47 0.0008
846 WITHDRAWAL SYNDROME 32 0.0008
847 BLOOD GLUCOSE ABNORMAL 14 0.0008
848 ILL-DEFINED DISORDER 46 0.0008
849 ADVERSE REACTION 10 0.0008
850 GASTROENTERITIS 11 0.0008
851 ASPARTATE AMINOTRANSFERASE INCREASED 40 0.0008
852 PREGNANCY 15 0.0007
853 BREAST CANCER FEMALE 20 0.0007
854 CARDIAC FAILURE 60 0.0007
855 LABORATORY TEST ABNORMAL 22 0.0007
856 LIVER FUNCTION TEST INCREASED 16 0.0007
857 INJECTION SITE SWELLING 56 0.0007
858 MANIA 12 0.0007
859 INJECTION SITE BRUISING 58 0.0007
860 CORONARY ARTERY DISEASE 22 0.0007
861 NEEDLE ISSUE 21 0.0007
862 OSTEOMYELITIS 13 0.0007
863 CARDIO-RESPIRATORY ARREST 30 0.0007
864 INJECTION SITE RASH 22 0.0007
865 EMOTIONAL DISORDER 22 0.0007
866 GLYCOSYLATED HAEMOGLOBIN INCREASED 18 0.0007
867 ANGER 24 0.0007
868 LUNG INFECTION 11 0.0007
869 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
870 INJECTION SITE REACTION 48 0.0007
871 PLEURAL EFFUSION 42 0.0007
872 DEVICE BREAKAGE 28 0.0007
873 ABSCESS 11 0.0007
874 DEVICE USE ISSUE 12 0.0007
875 BLOOD GLUCOSE INCREASED 129 0.0007
876 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
877 PULMONARY FIBROSIS 13 0.0007
878 DRUG ERUPTION 12 0.0007
879 INJECTION SITE MASS 25 0.0007
880 TARDIVE DYSKINESIA 19 0.0007
881 HAEMORRHAGE 70 0.0007
882 PALLOR 18 0.0007
883 DEATH 568 0.0007
884 RESPIRATORY ARREST 18 0.0007
885 HEMIPARESIS 11 0.0006
886 CYTOKINE RELEASE SYNDROME 13 0.0006
887 ASCITES 19 0.0006
888 EMOTIONAL DISTRESS 78 0.0006
889 PRODUCT ADHESION ISSUE 23 0.0006
890 BONE DENSITY DECREASED 20 0.0006
891 PLATELET COUNT DECREASED 68 0.0006
892 NEUTROPHIL COUNT DECREASED 26 0.0006
893 PSORIASIS 83 0.0006
894 ARRHYTHMIA 30 0.0006
895 DEEP VEIN THROMBOSIS 41 0.0006
896 ACCIDENTAL OVERDOSE 23 0.0006
897 TOOTH LOSS 13 0.0006
898 PRODUCT SUBSTITUTION ISSUE 36 0.0006
899 PULMONARY HYPERTENSION 13 0.0006
900 SEPTIC SHOCK 27 0.0006
901 RHEUMATOID ARTHRITIS 69 0.0006
902 INCORRECT DRUG ADMINISTRATION DURATION 17 0.0006
903 COLITIS ULCERATIVE 27 0.0006
904 HYPERGLYCAEMIA 22 0.0006
905 HYPOGLYCAEMIA 29 0.0006
906 MEDICATION ERROR 33 0.0006
907 INJECTION SITE PRURITUS 39 0.0006
908 TACHYCARDIA 51 0.0006
909 INTENTIONAL DRUG MISUSE 12 0.0006
910 CEREBRAL INFARCTION 14 0.0006
911 INJURY 40 0.0006
912 DISEASE RECURRENCE 27 0.0006
913 DYSTONIA 11 0.0006
914 INJECTION SITE ERYTHEMA 69 0.0006
915 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
916 DEVICE MALFUNCTION 39 0.0006
917 INJECTION SITE PAIN 170 0.0006
918 DEVICE LEAKAGE 24 0.0006
919 LOWER RESPIRATORY TRACT INFECTION 25 0.0005
920 ANAPHYLACTIC SHOCK 14 0.0005
921 ACNE 41 0.0005
922 RASH GENERALISED 14 0.0005
923 INJURY ASSOCIATED WITH DEVICE 11 0.0005
924 LUNG NEOPLASM MALIGNANT 22 0.0005
925 INCORRECT DOSE ADMINISTERED BY DEVICE 14 0.0005
926 METABOLIC ACIDOSIS 17 0.0005
927 ACCIDENTAL EXPOSURE TO PRODUCT 54 0.0005
928 EPILEPSY 16 0.0005
929 HYPERKALAEMIA 18 0.0005
930 CARDIOVASCULAR DISORDER 13 0.0005
931 RESPIRATORY DISTRESS 14 0.0005
932 INJECTION SITE HAEMORRHAGE 40 0.0005
933 APPLICATION SITE PAIN 11 0.0005
934 MYOCARDIAL INFARCTION 87 0.0005
935 HAEMATURIA 17 0.0005
936 PULMONARY EMBOLISM 47 0.0005
937 MULTIPLE ORGAN DYSFUNCTION SYNDROME 14 0.0005
938 PNEUMONITIS 13 0.0005
939 C-REACTIVE PROTEIN INCREASED 17 0.0005
940 RESPIRATORY FAILURE 34 0.0005
941 AGGRESSION 23 0.0005
942 NO ADVERSE EVENT 83 0.0005
943 GENERAL PHYSICAL HEALTH DETERIORATION 53 0.0005
944 DRUG-INDUCED LIVER INJURY 14 0.0004
945 JAUNDICE 12 0.0004
946 ABASIA 11 0.0004
947 OSTEONECROSIS OF JAW 11 0.0004
948 BLOOD BILIRUBIN INCREASED 12 0.0004
949 TOXICITY TO VARIOUS AGENTS 74 0.0004
950 PLASMA CELL MYELOMA 17 0.0004
951 GASTRIC CANCER 11 0.0004
952 HAEMATEMESIS 11 0.0004
953 DRUG RESISTANCE 11 0.0004
954 INTERNATIONAL NORMALISED RATIO INCREASED 12 0.0004
955 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
956 LIVER FUNCTION TEST ABNORMAL 12 0.0004
957 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 12 0.0004
958 BREAST CANCER 38 0.0004
959 ACUTE MYOCARDIAL INFARCTION 12 0.0004
960 DISEASE PROGRESSION 48 0.0004
961 NEOPLASM PROGRESSION 14 0.0004
962 SUICIDE ATTEMPT 24 0.0004
963 VAGINAL HAEMORRHAGE 17 0.0004
964 OVERDOSE 82 0.0004
965 ABORTION SPONTANEOUS 15 0.0004
966 INTENTIONAL OVERDOSE 24 0.0004
967 EXPOSURE DURING PREGNANCY 23 0.0004
968 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 17 0.0004
969 DRUG ADMINISTRATION ERROR 11 0.0004
970 MALIGNANT NEOPLASM PROGRESSION 35 0.0003
971 VISUAL ACUITY REDUCED 11 0.0003
972 DRUG WITHDRAWAL SYNDROME 28 0.0003
973 COMA 15 0.0003
974 SKIN BURNING SENSATION 22 0.0003
975 ANGIOEDEMA 13 0.0003
976 DEVICE DIFFICULT TO USE 18 0.0003
977 INTERSTITIAL LUNG DISEASE 13 0.0003
978 RHABDOMYOLYSIS 11 0.0003
979 SKIN IRRITATION 12 0.0003
980 MATERNAL EXPOSURE DURING PREGNANCY 20 0.0002
981 PROSTATE CANCER 18 0.0002
982 NEUTROPENIA 30 0.0002
983 PANCYTOPENIA 12 0.0002
984 THROMBOCYTOPENIA 24 0.0002
985 FEBRILE NEUTROPENIA 14 0.0002
986 DRUG DOSE OMISSION BY DEVICE 16 0.0002
987 DRUG DEPENDENCE 24 0.0001
988 DRUG ABUSE 12 0.0001